ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05162	Measles	4/11	120/7206	2.20556234989e-05
ko05222	Small cell lung cancer	3/11	89/7206	0.000279754235168
ko00623	Toluene degradation	1/11	1/7206	0.00152650568971
ko00361	Chlorocyclohexane and chlorobenzene degradation	1/11	1/7206	0.00152650568971
ko00364	Fluorobenzoate degradation	1/11	1/7206	0.00152650568971
ko05224	Breast cancer	3/11	174/7206	0.00197939162473
ko04622	RIG-I-like receptor signaling pathway	2/11	62/7206	0.00381105234612
ko05200	Pathways in cancer	4/11	492/7206	0.00481323401759
ko05134	Legionellosis	2/11	74/7206	0.00538934631348
ko05140	Leishmaniasis	2/11	75/7206	0.00553238862459
ko05212	Pancreatic cancer	2/11	83/7206	0.006739336873
ko05220	Chronic myeloid leukemia	2/11	85/7206	0.0070582953544
ko05218	Melanoma	2/11	85/7206	0.0070582953544
ko04657	IL-17 signaling pathway	2/11	87/7206	0.00738406855637
ko05133	Pertussis	2/11	87/7206	0.00738406855637
ko04064	NF-kappa B signaling pathway	2/11	96/7206	0.00893339902767
ko04620	Toll-like receptor signaling pathway	2/11	100/7206	0.00966518043404
ko04010	MAPK signaling pathway	3/11	321/7206	0.0110652176575
ko04660	T cell receptor signaling pathway	2/11	124/7206	0.0145955156759
ko05145	Toxoplasmosis	2/11	126/7206	0.0150469939754
ko05142	Chagas disease (American trypanosomiasis)	2/11	130/7206	0.0159681778674
ko04380	Osteoclast differentiation	2/11	134/7206	0.0169134375484
ko04933	AGE-RAGE signaling pathway in diabetic complications	2/11	135/7206	0.0171534825044
ko04151	PI3K-Akt signaling pathway	3/11	390/7206	0.0187468328814
ko05160	Hepatitis C	2/11	153/7206	0.0217239319139
ko04621	NOD-like receptor signaling pathway	2/11	157/7206	0.0228024252113
ko04722	Neurotrophin signaling pathway	2/11	160/7206	0.0236259323509
ko05161	Hepatitis B	2/11	173/7206	0.027336649755
ko04218	Cellular senescence	2/11	177/7206	0.0285239901706
ko05168	Herpes simplex infection	2/11	182/7206	0.0300376798073
ko05152	Tuberculosis	2/11	187/7206	0.0315837088845
ko05167	Kaposi's sarcoma-associated herpesvirus infection	2/11	191/7206	0.0328434922692
ko00531	Glycosaminoglycan degradation	1/11	23/7206	0.0345782676421
ko05169	Epstein-Barr virus infection	2/11	206/7206	0.0377451036459
ko01523	Antifolate resistance	1/11	30/7206	0.0448842130032